Skip to content

Ferrum phosphoricum in Anaemia

Effectiveness of Ferrum phosphoricum 6x in Increasing Haemoglobin Levels in Anaemia among the Women of Reproductive Age Group: A comparative Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062641
Enrollment
150
Registered
2024-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D53- Nutritional anemias

Interventions

Intervention1: Homoeopathic Medicine, Ferrum Phosphoricum: Ferrum phos 6X will be given on the basis of the presence of an indication of the medicine Ferrum phosphoricum in patients with anemia. All t

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female aged 18-45 years, 2. Diagnosed case of Anaemia with Haemoglobin level more than or equal to 8 gm per dl to less than 12 gm per dl 3. Willing to give consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients unable to give informed consent or unwilling to take part in the study. 2. Pregnant and lactating mother 3. Patients who are self-reported immune-compromised. 4. Patients with any self-reported haemoglobinopathies like Thalasaemia, Sickle cell anemia etc. 5. Patients suffering from Anaemia with chronic illnesses like diabetes, cardiac complications, renal failure etc. 6. Patient with diagnosed case of inadequate organ and bone marrow functioning due to aplasia and or malignancy. 7. Patient with psychiatric disorder and or history of substance abuse 8. Patient under homoeopathic treatment for any chronic disease within last 1 month. 9. Patient who are already under Iron supplementation in last 1 month before the enrollment.

Design outcomes

Primary

MeasureTime frame
Haemoglobin levelTimepoint: At the baseline and at the end of each month till 3 months of follow-up.

Secondary

MeasureTime frame
Quality of life SF36 ScoreTimepoint: At the baseline and at the end of every months till 3 months;Serum biochemical markers, Serum ferritin, Transferrin, TIBCTimepoint: At the baseline and at the end of 3rd month

Countries

India

Contacts

Public ContactMadhumita Sadhukhan

Central Council for Research in Homoeopathy

dr.msadhukhan@gmail.com9331866008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026